Pharmaceutical Unit Dose Packaging Market Size, Share, Value and Forecast 2032

Pharmaceutical Unit Dose Packaging Market Insights

According to Zion Market Research, the global Pharmaceutical Unit Dose Packaging Market was worth USD 32.52 Billion in 2023. The market is forecast to reach USD 62.35 Billion by 2032, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Pharmaceutical Unit Dose Packaging Market industry over the next decade.

Request Free Sample

Pharmaceutical Unit Dose Packaging Market: Overview

Single-dose packaging was established because of continuous packaging industry innovation to provide patients with safe and effective medication dispensing. This type of packaging was thought to be the safest because there was no risk of the prescription being refilled, and it also reduced the number of misdoes. These benefits, combined with changing lifestyles and the growing dominance of modern style culture, resulted in a broader range of uses for this product. Furthermore, the convenience and mobility benefits associated with this type of packaging are driving demand for single dosage packing.

As the number of COVID patients grows, new hospitals and COVID-19 centers are springing up all around the world, increasing the demand for medical treatments. By avoiding the risk of handling and pouring out liquid doses from the same bottle, unit dosage packaging benefits current and post-Covid healthcare delivery procedures. Furthermore, the increased need for the Covid-19 vaccine, as well as the government's high number of immunization programmes, has resulted in a surge in demand for unit dose packaging in vials.

Pharmaceutical Unit Dose Packaging Market: Growth Factors

The major growth factors of Pharmaceutical Unit Dose Packaging Market are: Growing demand for blister packaging, Consumer preference for blister packaging, which is unit-dose packaging, has gradually shifted away from traditional bottles for pharmaceutical items. In the healthcare business, blister packs are used to package pharmaceuticals and medical devices. They are also used in a variety of consumer items, industrial items, and food-related applications. Blister packaging also uses fewer resources for packing, takes up less retail shelf space, and has a great hang-hook display. As a result, blister packs are less expensive than alternative packaging styles such as hard bottles, making them cost-effective.

In the healthcare industry, there are an increasing number of regulatory regulations to maintain GMP compliance, Regulatory bodies such as the Food and Drug Administration (US), the European Medicines Agency, and the Pharmaceuticals and Medical Devices Agency (Japan) monitor manufacturers' compliance with Current Good Manufacturing Practice (CGMP) rules to assure the quality of pharmaceuticals and medical devices. The minimal criteria for the procedures, facilities, and controls utilized in the manufacture, processing, and packing of pharmaceuticals and medical devices are outlined in CGMP rules. The restrictions in place ensure that products are safe to use and contain the ingredients and strength that they promise.

Pharmaceutical Unit Dose Packaging Market: Segment Analysis

Based on End Users Pharmaceutical Unit Dose Packaging Market is segmented into Orals, Respiratory Therapy, Wound Care, Biologics, Injectable, and Ophthalmic. During the predicted period, pharmaceutical and biotechnology companies are predicted to increase the most. In the overall pharmaceutical packaging market, the oral medication delivery route is the largest segment. The rising incidence of chronic diseases, improved patient compliance, reformulation, and repositioning of medications employing sophisticated oral delivery technologies are all factors contributing to the big market size.

Large pharmaceutical companies have made significant expenditures to improve their in-house expertise in the development of oral drug delivery systems. The market has also grown due to rising demand for self-administration and home healthcare equipment, as well as the growing use of inhalers and transdermal patches for chronic conditions such as migraine, diabetes, cancer pain, and asthma.

Based on material, Pharmaceutical Unit Dose Packaging Market is segmented into Paper Pharmaceutical & Paperboard Pharmaceutical Unit Dose Packaging, Glass Pharmaceutical Unit Dose Packaging, Aluminum Pharmaceutical Unit Dose Packaging and Plastic & Polymers Pharmaceutical Unit Dose Packaging. Plastics and polymers such as polyvinyl chloride, polypropylene, polyethylene terephthalate, polyethylene, and polystyrene, among others, are commonly used to make pharmaceutical packaging. During the projected period, the polypropylene material is expected to expand at the fastest rate.

Polypropylene is a cost-effective polymer that is used extensively in the packaging sector. Polypropylene also has a unique mixture of physical, mechanical, thermal, and electrical properties. Furthermore, it is resistant to organic solvents, degreasing chemicals, and electrolytic attack. The glass material segment reported for a revenue share of 20% percent in 2023. Glass is an inorganic material that is primarily made up of silica. Glass is used for manufacturing containers that are used for packing pharmaceutical products including parenteral, and non-parenteral preparations as well as pharmaceutical powders, among others.

Pharmaceutical Unit Dose Packaging Market: Report Scope

Pharmaceutical Unit Dose Packaging Market: Regional Analysis

The presence of large pharmaceutical markets such as the United States, Canada, and Mexico characterizes the region. The United States has the world's largest pharmaceutical market. The industry has been fueled by the country's extensive healthcare system, high per capita income, and significant investments in drug discovery. Furthermore, the presence of large corporations such as Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., Bristol-Myers Squibb Company, and AbbVie Inc. is expected to boost regional growth.

Request Free SampleThe Asia Pacific region is projected to grow at a CAGR of Over the forecast period, Asia Pacific is expected to grow at the fastest rate. The most important regional markets are China, India, Japan, and South Korea. In the future years, steady economic expansion combined with strong population growth in the region is predicted to stimulate product demand. Furthermore, increased government restrictions for drug safety are projected to fuel regional expansion.

Key Market Players & Competitive Landscape

Some of key players in Pharmaceutical Unit Dose Packaging Market are

• Pfizer Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• Bristol-Myers Squibb Company
• AbbVie Inc.
• UDG Healthcare plc
• Comar LLC
• Berry Global Inc.
• Gerresheimer AG
• Amcor plc

The global Pharmaceutical Unit Dose Packaging market is segmented as follows:

By Material

• Paper Pharmaceutical & Paperboard Pharmaceutical Unit Dose Packaging
• Glass Pharmaceutical Unit Dose Packaging
• Aluminum Pharmaceutical Unit Dose Packaging
• Plastic & Polymers Pharmaceutical Unit Dose Packaging

By Product

• Prefilled Syringes Cartridges
• Vials Pharmaceutical Unit Dose Packaging
• Ampoules Pharmaceutical Unit Dose Packaging
• Blisters Pharmaceutical Unit Dose Packaging

By End-Users

• Orals
• Respiratory Therapy
• Wound Care
• Biologics
• Injectable
• Ophthalmic

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa